NOVO — August 2022
-
ANALYSIS-U.S. move to negotiate drug prices a rare defeat for Big Pharma https://www.proinvestor.com/investornyt/866377/analysis-us-move-to-negotiate-drug-prices-a-rare-defeat-for-big-pharma
-
Test
-
Mandagens aviser med SAS, FLSmidth og Novo Nordisk https://www.proinvestor.com/investornyt/869397/mandagens-aviser-med-sas-flsmidth-og-novo-nordisk
-
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=131155
-
Novo Nordisk-aktien kraftigt i vejret efter "meget stærke resultater". https://www.proinvestor.com/investornyt/869508/novo-nordisk-aktien-kraftigt-i-vejret-efter-meget-staerke-resultater
-
Dejligt...:-)
-
USD ikke set stærkere i 20 år er gode nyheder for Novo https://www.proinvestor.com/boards/105499
-
Onsdagens aviser med Novo Nordisk, Sydbank og Danfoss https://www.proinvestor.com/investornyt/870502/onsdagens-aviser-med-novo-nordisk-sydbank-og-danfoss
-
Fra debatten: https://www.proinvestor.com/boards/105488/
-
Der er fart på i dag:-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind